A B-cell developmental gene regulatory network is activated in infant AML
Infant Acute Myeloid Leukemia (AML) is a poorly-addressed, heterogeneous malignancy distinguished by surprisingly few mutations per patient but accompanied by myriad age-specific translocations. These characteristics make treatment of infant AML challenging. While infant AML is a relatively rare dis...
Guardado en:
Autores principales: | Hamid Bolouri, Rhonda Ries, Laura Pardo, Tiffany Hylkema, Wanding Zhou, Jenny L. Smith, Amanda Leonti, Michael Loken, Jason E. Farrar, Timothy J. Triche, Soheil Meshinchi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d13c5f80eaca472491942928dac038df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A B-cell developmental gene regulatory network is activated in infant AML.
por: Hamid Bolouri, et al.
Publicado: (2021) -
TARGETED THERAPY IN AML TREATMENT
por: Giovanni Martinelli
Publicado: (2021) -
Developmental change of the biorbital angle in normal Japanese infants
por: Yagasaki T, et al.
Publicado: (2018) -
Cis-regulatory timers for developmental gene expression.
por: Lionel Christiaen
Publicado: (2013) -
Developmental changes in social attention and oxytocin levels in infants and children
por: Minaho Nishizato, et al.
Publicado: (2017)